Trials / Completed
CompletedNCT04670575
Vivity Outcomes in Patients With Early Stage Glaucoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27 (actual)
- Sponsor
- Vance Thompson Vision · Academic / Other
- Sex
- All
- Age
- 45 Years
- Healthy volunteers
- —
Summary
The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens (IOL).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL | Patients with early stage glaucoma implanted with Vivity or Vivity Toric IOL |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2022-10-31
- Completion
- 2022-11-30
- First posted
- 2020-12-17
- Last updated
- 2024-05-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04670575. Inclusion in this directory is not an endorsement.